BioSpace News Archive

Business

CuraSen Therapeutics Appoints Kathleen Sereda Glaub Chief Executive Officer

October 15, 2024
·
5 min read
Press Releases

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

October 15, 2024
·
9 min read
Press Releases

Thryv Therapeutics Receives Positive Top-Line Results from Wave I Part 2 Clinical Study in Long QT Syndrome Type 2 and Type 3 Patients

October 15, 2024
·
3 min read
Drug Development

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

October 15, 2024
·
5 min read
Press Releases

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market

October 15, 2024
·
3 min read
News

Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting

October 15, 2024
·
5 min read
Press Releases

Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme And Drive Next Stage of Growth

October 15, 2024
·
2 min read
Drug Development

Beacon Therapeutics Announces Positive 24-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosa

October 15, 2024
·
4 min read
Press Releases

Paragonix Technologies Announces First Pediatric Use of BAROguard Lung Preservation System

October 15, 2024
·
3 min read
News

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

October 15, 2024
·
1 min read